Current treatment in rheumatoid arthritis: a review including nanotechnology and gene therapy

Malekzadeh, Najmeh (2017) Current treatment in rheumatoid arthritis: a review including nanotechnology and gene therapy. Reviews in Clinical Medicine, 4 (2). pp. 62-68.

[img]
Preview
Text
RCM_Volume 4_Issue 2_Pages 62-68.pdf

Download (350kB) | Preview
Official URL: http://rcm.mums.ac.ir/article_7614.html

Abstract

Rheumatoid arthritis (RA) is a common inflammatory disease affecting approximately 1 of the adult population worldwide. Before new treatments were available, unchecked RA caused notable inability and mortality .It is now accepted that primary diagnosis and treatment are essential and useful. Progress in therapy of RA has made it possible to deeply influence signs and symptoms as the period that joint destructed in inflammatory arthritis. Earlier and more efficient treatment becomes visible to significantly improve the prognosis of this disease. In this article, the old and new methods for treatment rheumatoid arthritis and their limitation and benefits were reviewed. These methods include nonsteroidal anti-inflammatory drug (NSAIDs), glucocorticoids(GC) that are a class of steroid hormones, disease-modifying anti-rheumatic drugs (DMARDs), biological agents that can be divided in two groups of monoclonal antibodies and teeny molecules, bisphosphonate therapy, nanotechnology, oral tolerance, photodynamic therapy, gene therapy, bone marrow transplantation, liposomes, superparamagnetic iron oxide nano particles (SPIONs).

Item Type: Article
Subjects: QU Biochemistry
Divisions: Journals > Reviews in Clinical Medicine
Depositing User: RCM RCM
Date Deposited: 05 Sep 2017 13:57
Last Modified: 05 Sep 2017 13:57
URI: http://eprints.mums.ac.ir/id/eprint/565

Actions (login required)

View Item View Item